PRELUDE CAPITAL MANAGEMENT, LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1387508
NEW YORK, NY
Position in TEVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,667,696
+$1,500,818 QoQ
Shares Held
154,970
+52.7% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
13 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Derivatives in TEVA
reported options exposure · as of Jun 30, 2021CallValue
$0
CallShares
0
PutValue
$2,871,000
PutShares
290,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $21,122,108 across 18 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (22.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
154,970 | $4,667,696 | |
| 2 | ETON |
Eton Pharmaceuticals, Inc.
|
188,802 | $4,659,633 | |
| 3 | CRON |
Cronos Group Inc.
|
1,500,000 | $3,765,000 | |
| 4 | LQDA |
Liquidia Corp
|
40,595 | $1,532,055 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,345 | $1,390,538 | |
| 6 | VTRS |
Viatris Inc
|
102,186 | $1,380,532 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
50,735 | $1,146,611 | |
| 8 | ALKS |
Alkermes plc.
|
16,928 | $598,574 |
All Filings in TEVA
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,667,696 | 154,970 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $3,166,878 | 101,470 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $3,098,437 | 153,388 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,573,414 | 153,545 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $677,509 | 44,080 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $455,787 | 20,680 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $299,582 | 16,625 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $266,857 | 16,422 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $230,388 | 16,328 | Shares | Other | 2024-05-15 | |
| 2021-06-30 | $2,871,000 | 290,000 | Put | Sole | 2021-08-16 | |
| 2020-09-30 | $16,614 | 1,844 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $1,233 | 100 | Call | Other | 2020-08-14 | |
| 2020-03-31 | $26,940 | 3,000 | Call | Other | 2020-05-15 | |
| 2020-03-31 | $30,532 | 3,400 | Put | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||